Disruptions could raise drug costs or cause shortages of antibiotics, antidiabetics and cardiovascular drugs, many of which rely on petrochemical-based APIs.
The MoU is an extension of EIL’s first order secured in 2018 and completed in 2024 under which it built a 6,50,000/bpd oil refinery for the same Lagos-headquartered Dangote group.
C.O.I.M. S.p.A. will acquire the business for a consideration of at least 8.5 times the adjusted EBITDA of 2.12 million British Pounds, a value determined jointly by both parties.